These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 25741635)

  • 21. Understanding the adverse effects of ocriplasmin - reply.
    Johnson MW; Fahim AT
    JAMA Ophthalmol; 2015 Feb; 133(2):230. PubMed ID: 25375273
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of ocriplasmin on the management of macular holes: assessment of the clinical relevance of ocriplasmin.
    Moisseiev J; Moroz I; Katz G
    JAMA Ophthalmol; 2014 Jun; 132(6):709-13. PubMed ID: 24723009
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Understanding the adverse effects of ocriplasmin - reply.
    Tibbetts MD; Reichel E; Witkin AJ
    JAMA Ophthalmol; 2015 Feb; 133(2):229-30. PubMed ID: 25375214
    [No Abstract]   [Full Text] [Related]  

  • 24. Assessment of retinal alterations after intravitreal ocriplasmin with spectral-domain optical coherence tomography.
    Itoh Y; Kaiser PK; Singh RP; Srivastava SK; Ehlers JP
    Ophthalmology; 2014 Dec; 121(12):2506-2507.e2. PubMed ID: 25208855
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment outcomes and spectral-domain optical coherence tomography findings of eyes with symptomatic vitreomacular adhesion treated with intravitreal ocriplasmin.
    Warrow DJ; Lai MM; Patel A; Raevis J; Berinstein DM
    Am J Ophthalmol; 2015 Jan; 159(1):20-30.e1. PubMed ID: 25220823
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rhegmatogenous retinal detachment following intravitreal ocriplasmin.
    Madi HA; Haynes RJ; Depla D; de la Cour MD; Lesnik-Oberstein S; Muqit MM; Patton N; Price N; Steel DH
    Graefes Arch Clin Exp Ophthalmol; 2016 Dec; 254(12):2333-2338. PubMed ID: 27278373
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bilateral vitreomacular traction resolved with a single intravitreal ocriplasmin injection.
    Katz RS
    Ophthalmic Surg Lasers Imaging Retina; 2014; 45(3):239-42. PubMed ID: 24708167
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic Serous Macular Detachments and Visual Disturbance Complicating Consecutive Cases of Symptomatic Vitreomacular Adhesion With Macular Hole Treated With Ocriplasmin.
    Luttrull JK
    Ophthalmic Surg Lasers Imaging Retina; 2015 Oct; 46(9):976-8. PubMed ID: 26469240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of intravitreal ocriplasmin on vitreomacular traction and full-thickness macular holes.
    Sharma P; Juhn A; Houston SK; Fineman M; Chiang A; Ho A; Regillo C
    Am J Ophthalmol; 2015 May; 159(5):861-7.e2. PubMed ID: 25660387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SAFETY PROFILE OF OCRIPLASMIN FOR SYMPTOMATIC VITREOMACULAR ADHESION: A Comprehensive Analysis of Premarketing and Postmarketing Experiences.
    Hahn P; Chung MM; Flynn HW; Huang SS; Kim JE; Mahmoud TH; Sadda SR; Dugel PU
    Retina; 2015 Jun; 35(6):1128-34. PubMed ID: 25635575
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early evolution of the vitreomacular interface and clinical efficacy after ocriplasmin injection for symptomatic vitreomacular adhesion.
    Meyer JC; Shah GK; Blinder KJ; Waheed NK; Reichel E; Stalmans P; Singer M; Tewari A
    Ophthalmic Surg Lasers Imaging Retina; 2015 Feb; 46(2):209-16. PubMed ID: 25707046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ELLIPSOID ZONE MAPPING AND OUTER RETINAL CHARACTERIZATION AFTER INTRAVITREAL OCRIPLASMIN.
    Itoh Y; Ehlers JP
    Retina; 2016 Dec; 36(12):2290-2296. PubMed ID: 27341665
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lamellar macular hole after intravitreal ocriplasmin injection.
    Chod RB; Goodrich C; Saxena S; Akduman L
    BMJ Case Rep; 2015 Jan; 2015():. PubMed ID: 25576512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Efficacy and Safety Profile of Ocriplasmin Treatment - an Update].
    Compera D; Priglinger S; Schumann RG
    Klin Monbl Augenheilkd; 2019 Jun; 236(6):791-797. PubMed ID: 28599332
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ocriplasmin for foveal schisis in X-linked retinoschisis.
    Patel A; Morse L
    Retin Cases Brief Rep; 2015; 9(3):248-51. PubMed ID: 26002140
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ocriplasmin use in a selected case with preserved visual acuity.
    Rossi S; Orrico A; Melillo P; Testa F; Simonelli F; Della Corte M
    BMC Ophthalmol; 2015 Oct; 15():146. PubMed ID: 26511080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sterile endophthalmitis after intravitreal ocriplasmin injection: report of a single case.
    Han IC; Scott AW
    Retin Cases Brief Rep; 2015; 9(3):242-4. PubMed ID: 25790316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CORRELATION BETWEEN OPTICAL COHERENCE TOMOGRAPHIC HYPERREFLECTIVE FOCI AND VISUAL OUTCOMES AFTER ANTI-VEGF TREATMENT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION AND POLYPOIDAL CHOROIDAL VASCULOPATHY.
    Lee H; Ji B; Chung H; Kim HC
    Retina; 2016 Mar; 36(3):465-75. PubMed ID: 26076214
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Portuguese Experience with Ocriplasmin in Clinical Practice.
    Figueira J; Martins D; Pessoa B; Ferreira N; Meireles A; Sampaio A; Carneiro Â; Vaz F; Nascimento J; Moreno N; Roque J; Domingues M; Flores R; Teixeira C; Conde E; Henriques F; Proença H; Pita Negrão J; Barbosa M; Silva R; Vaz-Pereira S; Pereira Neves P; Gomes N; Raimundo M;
    Ophthalmic Res; 2016; 56(4):186-192. PubMed ID: 27438077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spectral domain optical coherence tomography findings in long-term silicone oil-related visual loss.
    Shalchi Z; Mahroo OA; Shunmugam M; Mohamed M; Sullivan PM; Williamson TH
    Retina; 2015 Mar; 35(3):555-63. PubMed ID: 25127046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.